COVID-19 vaccines have demonstrated high efficacy in clinical trials, particularly in preventing severe disease, hospitalization, and death. For instance, mRNA vaccines like Pfizer-BioNTech and Moderna have shown efficacy rates of around 95% in preventing symptomatic COVID-19. However, effectiveness can vary against different variants of the virus. Booster doses have been recommended to maintain high levels of protection over time.
